Practice Areas - Debt Capital Markets Law Firms and Lawyers
Deal Date: | 24-01-2013 | Practice Area: | Debt Capital Markets |
Deal Title: | Theravance Convertible Notes due 2023 | Industry: | Pharmaceuticals & Biotechnology |
Description: |
Davis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated as sole book-running manager of the registered public offering by Theravance, Inc. of USD287.5 million aggregate principal amount of its 2.125% convertible subordinated notes due 2023 (which included the full exercise of the over-allotment option). In addition, Davis Polk advised Bank of America, N.A. as the counterparty to capped call transactions in connection with the convertible notes offering.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Peter M. Lamb and Sara Chang. The equity derivatives team included partner Mark M. Mendez, associate Jonathan Armstrong and law clerk D. Tina Wang. Partner Rachel D. Kleinberg and associate William A. Curran provided tax advice. Kimberly Kakade and Cassandra Aguirre were the legal assistants for the transaction. Members of the Davis Polk team are based in the Menlo Park and New York offices.
|
||
Financial Center: | Silicon Valley | Value: | 100.01-500.00 |
Advised Party: | Lead Manager | Law Firm | Davis Polk |
Issuer Jurisdiction: | United States | Listing Jurisdiction: | United States |
Classification: |
Equity-Linked Securities Convertible Bonds |
Lawyer | Alan F Denenberg |